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Abstract
Here we present a method for the simultaneous segmentation of white matter lesions and normal-appearing neuroanatomical
structures from multi-contrast brain MRI scans of multiple sclerosis patients. The method integrates a novel model for white
matter lesions into a previously validated generative model for whole-brain segmentation. By using separate models for the shape
of anatomical structures and their appearance in MRI, the algorithm can adapt to data acquired with different scanners and imaging
protocols without retraining. We validate the method using three disparate datasets, showing state-of-the-art performance in white
matter lesion segmentation while simultaneously segmenting dozens of other brain structures. We further demonstrate that the
contrast-adaptive method can also be applied robustly to MRI scans of healthy controls, and replicate previously documented
atrophy patterns in deep gray matter structures in MS. The algorithm is publicly available as part of the open-source neuroimaging
package FreeSurfer.
Keywords: lesion segmentation, multiple sclerosis, whole-brain segmentation, generative model.
1. Introduction
Multiple sclerosis (MS) is the most frequent chronic inflam-
matory autoimmune disorder of the central nervous system,
causing progressive damage and disability. The disease affects
nearly half a million Americans and 2.5 million individuals
world-wide (Rosati, 2001; Goldenberg, 2012), generating more
than $10 billion in annual healthcare spending in the United
States alone (Adelman et al., 2013).
The ability to diagnose MS and track its progression has been
greatly enhanced by magnetic resonance imaging (MRI), which
can detect characteristic brain lesions in white and gray mat-
ter (Bakshi et al., 2008; Lo¨vblad et al., 2010; Blystad et al.,
2015; Garcı´a-Lorenzo et al., 2013). Lesions visualized by MRI
are up to an order of magnitude more sensitive in detecting
disease activity compared to clinical assessment (Filippi et al.,
2006). The prevalence and dynamics of white matter lesions are
thus used clinically to diagnose MS (Thompson et al., 2018),
define disease stages and to determine the efficacy of therapeu-
tic regimen (Sormani, 2013). MRI is also an unparalleled tool
for characterizing brain atrophy, which occurs at a faster rate in
patients with MS compared to healthy controls (Barkhof et al.,
2009; Azevedo et al., 2018) and, especially in deep gray matter
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structures and the cerebral cortex, has been shown to correlate
with measures of disability (Geurts et al., 2012).
Although manual labeling remains the most accurate way
of delineating white matter lesions in MS (Commowick et al.,
2018), this approach is very cumbersome and in itself prone
to considerable intra- and inter-rater disagreement (Zijdenbos
et al., 1998). Furthermore, manually labeling various normal-
appearing brain structures to assess atrophy is simply too time
consuming to be practically feasible. Therefore, there is a clear
need for automated tools that can reliably and efficiently char-
acterize the morphometry of white matter lesions, various neu-
roanatomical structures, and their changes over time directly
from in vivo MRI. Such tools are of great potential value for
diagnosing disease, tracking progression, and evaluating treat-
ment. They can also help in obtaining a better understanding
of underlying disease mechanisms, and to facilitate more effi-
cient testing in clinical trials. Ultimately, automated software
tools may help clinicians to prospectively identify which pa-
tients are at highest risk of future disability accrual, leading
to better counseling of patients and better overall clinical out-
comes.
Despite decades of methodological development
(cf. (Garcı´a-Lorenzo et al., 2013) or (Danelakis et al.,
2018)), currently available computational tools for analyzing
MRI scans of MS patients remain limited in a number of
important ways:
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- Poor generalizability: Existing tools are often developed
and tested on very specific imaging protocols, and may not
be able to work on data that is acquired differently. Espe-
cially with the strong surge of supervised learning in recent
years, where the relationship between image appearance
and segmentation labels in training scans is directly and
statically encoded, the segmentation performance of many
state-of-the-art algorithms will degrade substantially when
applied to data from different scanners and acquisition pro-
tocols (Garcı´a-Lorenzo et al., 2013; Valverde et al., 2019),
severely limiting their usefulness in practice.
- Dearth of available software: Despite the very large number
of proposed methods, most algorithms are only developed
and tested in-house, and very few tools are made publicly
available (Shiee et al., 2010; Schmidt et al., 2012; Grif-
fanti et al., 2016; Valverde et al., 2017). In order to se-
cure that computational methods will make a real practical
impact, they must be accompanied by software implemen-
tations that work robustly across a wide array of image
acquisitions; that are made publicly available; and that are
open-sourced, rigorously tested and comprehensively doc-
umented.
- Limitations in assessing atrophy: There is a lack of dedi-
cated tools for characterizing brain atrophy patterns in MS:
many existing methods characterize only aggregate mea-
sures such as global brain or gray matter volume (Smith
et al., 2002; Smeets et al., 2016) rather than individual
brain structures, or require that lesions are pre-segmented
so that their MRI intensities can be replaced with place-
holder values to avoid biased atrophy measures (Sdika
and Pelletier, 2009; Chard et al., 2010; Battaglini et al.,
2012; Gelineau-Morel et al., 2012; Ceccarelli et al., 2012;
Azevedo et al., 2018) (so-called lesion filling).
In order to address these limitations, we describe a new open-
source software tool for simultaneously segmenting white mat-
ter lesions and 41 neuroanatomical structures from MRI scans
of MS patients. An example segmentation produced by this
tool is shown in Fig. 1. By performing lesion segmentation in
the full context of whole-brain modeling, the method obviates
the need to segment lesions and assess atrophy in two sepa-
rate processing phases, as currently required in lesion filling
approaches. The method works robustly across a wide range
of imaging hardware and protocols by completely decoupling
computational models of anatomy from models of the imag-
ing process, thereby side-stepping the intrinsic generalization
difficulties of supervised methods such as convolutional neural
networks. Our software implementation is freely available as
part of the FreeSurfer neuroimaging analysis package (Fischl,
2012).
To the best of our knowledge, only two other methods have
been developed for joint whole-brain and white matter lesion
segmentation in MS. (Shiee et al., 2010) model lesions as an
extra tissue class in an unsupervised whole-brain segmenta-
tion method (Bazin and Pham, 2008), removing false positive
detections of lesions using a combination of topological con-
Fig. 1: Segmentation of white matter lesions and 41 different brain structures
from the proposed method on T1w-FLAIR input. From left to right: sagittal,
coronal, axial view. From top to bottom: T1w, FLAIR, automatic segmentation.
straints and hand-crafted rules implementing various intensity-
and distance-based heuristics. However, the method segments
only a small set of neuroanatomical structures (10), and vali-
dation of this aspect was limited to a simulated MRI scan of
a single subject. (McKinley et al., 2019) use a cascade of two
convolutional neural networks, with the first one skull-stripping
individual image modalities and the second one generating the
actual segmentation. However, the whole-brain segmentation
performance of this method was only evaluated on a few struc-
tures (7). Furthermore, as a supervised method its applicability
on data that differs substantially from its training data will nec-
essarily be limited.
A preliminary version of this work was presented in Puonti
and Van Leemput (2016). Compared to this earlier work, the
current article employs more advanced models for the shape
and appearance of white matter lesions, and includes a more
thorough validation of the segmentation performance of the
proposed method, including an evaluation of the whole-brain
segmentation component and comparisons with human inter-
rater variability.
2. Contrast-adaptive whole-brain segmentation
We build upon a method for whole-brain segmentation called
Sequence Adaptive Multimodal SEGmentation (SAMSEG)
that we previously developed (Puonti et al., 2016), and that we
propose to extend with the capability to handle white matter
lesions. SAMSEG robustly segments 41 structures from head
MRI scans without any form of preprocessing or prior assump-
tions on the scanning platform or the number and type of pulse
2
sequences used. Since we build heavily on this method for the
remainder of the paper, we briefly outline its main characteris-
tics here.
SAMSEG is based on a generative approach, in which a for-
ward probabilistic model is inverted to obtain automated seg-
mentations. Let D = (d1, . . . ,dI) denote a matrix collecting
the intensities in a multi-contrast brain MR scan with I vox-
els, where the vector di = (d1i , . . . , d
N
i )
T contains the intensi-
ties in voxel i for each of the available N contrasts. Further-
more, let l = (l1, . . . , lI)T be the corresponding labels, where
li ∈ {1, . . .K} denotes one of the K possible segmentation labels
assigned to voxel i. SAMSEG estimates a segmentation l from
MRI data D by using a generative model, illustrated in black
in Fig. 2. According to this model, l is sampled from a seg-
mentation prior p(l|θl), after which D is obtained by sampling
from a likelihood function p(D|l, θd), where θl and θd are model
parameters with priors p(θl) and p(θd). Segmentation then con-
sists of inferring the unknown l from the observed D under this
model. In the following, we summarize the segmentation prior
and the likelihood used in SAMSEG, as well as the way the
resulting model is used to obtain automated segmentations.
2.1. Segmentation prior
To model the spatial configuration of various neuroanatom-
ical structures, we use a deformable probabilistic atlas as de-
tailed in (Puonti et al., 2016). In short, the atlas is based on a
tetrahedral mesh, where the parameters θl are the spatial posi-
tions of the mesh’s vertices, and p(θl) is a topology-preserving
deformation prior that prevents the mesh from tearing or fold-
ing (Ashburner et al., 2000). The model assumes conditional
independence of the labels between voxels for a given defor-
mation:
p(l|θl) =
I∏
i=1
p(li|θl),
and computes the probability of observing label k at voxel i as
p(li = k|θl) =
J∑
j=1
αkjψ
i
j(θl), (1)
where αkj are label probabilities defined at the J vertices of the
mesh, and ψij(θl) denotes a spatially compact, piecewise-linear
interpolation basis function attached to the jth vertex and eval-
uated at the ith voxel (Van Leemput, 2009).
The topology of the mesh, the mode of the deformation
prior p(θl), and the label probabilities αkj can be learned au-
tomatically from a set of segmentations provided as training
data (Van Leemput, 2009). This involves an iterative process
that combines a mesh simplification operation with a group-
wise nonrigid registration step to warp the atlas to each of
training subjects, and an Expectation Maximization (EM) al-
gorithm (Dempster et al., 1977) to estimate the label probabil-
ities αkjin the mesh vertices. The result is a sparse mesh that
encodes high-dimensional atlas deformations through a com-
pact set of vertex displacements. As described in (Puonti et al.,
2016), the atlas used in SAMSEG was derived from manual
whole-brain segmentations of 20 subjects, representing a mix
of healthy individuals and subjects with questionable or proba-
ble Alzheimer’s disease.
2.2. Likelihood function
For the likelihood function we use a Gaussian model for each
of the K different structures. We assume that the bias field arti-
fact can be modelled as a multiplicative and spatially smooth ef-
fect (Wells et al., 1996). For computational reasons, we use log-
transformed image intensities in D, and model the bias field as
a linear combination of spatially smooth basis functions that is
added to the local voxel intensities (Van Leemput et al., 1999).
Letting θd collect all bias field parameters and Gaussian means
and variances, the likelihood is defined as
p(D|l, θd) =
I∏
i=1
p(di|li, θd),
p(di|li = k, θd) = N(di|µk + Cφi,Σk),
C =

cT1
...
cTN
 , cn =

cn,1
...
cn,P
 , φi =

φi1
...
φiP
 ,
where P denotes the number of bias field basis functions, φip is
the basis function p evaluated at voxel i, and cn holds the bias
field coefficients for MRI contrast n. We use a flat prior for the
parameters of the likelihood: p(θd) ∝ 1.
2.3. Segmentation
For a given MRI scan D, segmentation proceeds by com-
puting a point estimate of the unknown model parameters θ =
{θd, θl}:
θˆ = arg max
θ
p(θ|D),
which effectively fits the model to the data. Details of this pro-
cedure are given in Appendix A. Once θˆ is found, the corre-
sponding maximum a posteriori (MAP) segmentation
lˆ = arg max
l
p(l|D, θˆ)
is obtained by assigning each voxel to the label with the highest
probability, i.e., lˆi = arg maxk wˆi,k, where 0 ≤ wˆi,k ≤ 1 are
probabilistic label assignments
wi,k =
N(di|µk + Cφi,Σk)p(li = k|θl)∑K
k′=1N(di|µk′ + Cφi,Σk′ )p(li = k′|θl)
(2)
evaluated at the estimated parameters θˆ. It is worth empha-
sizing that, since the class means and variances {µk,Σk} are
estimated from each target scan individually, the model auto-
matically adapts to each scan’s specific intensity characteristics
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– a property that we demonstrated experimentally on several
data sets acquired with different imaging protocols, scanners
and field strengths in Puonti et al. (2016).
Our implementation of this method, written in Python with
the exception of C++ parts for the computationally demanding
optimization of the atlas mesh deformation, is available as part
of the open-source package FreeSurfer1. It segments MRI brain
scans without any form of preprocessing such as skull stripping
or bias field correction, taking around 10 minutes to process
one subject on a state-of-the-art computer (measured on a ma-
chine with an Intel 12-core i7-8700K processor). As explained
in (Puonti et al., 2016), in our implementation we make use of
the fact that many neuroanatomical structures share the same
intensity characteristics in MRI to reduce the number of free
parameters in the model (e.g., all white matter structures share
the same Gaussian mean µk and variance Σk, as do most gray
matter structures). Furthermore, for some structures (e.g., non-
brain tissue) we use Gaussian mixture models instead of a sin-
gle Gaussian. In addition to using full covariance matrices Σk,
our implementation also supports diagonal covariances, which
is currently selected as the default behavior.
3. Modeling lesions
In order to make SAMSEG capable of additionally segment-
ing white matter lesions, we augment its generative model
by introducing a binary lesion map z = (z1, . . . , zI)T , where
zi ∈ {0, 1} indicates the presence of a lesion in voxel i.
The augmented model is depicted in Fig. 2, where the blue
parts indicate the additional components compared to the orig-
inal SAMSEG method. The complete model consists of a
joint (i.e., over both l and z simultaneously) segmentation
prior p(l, z|h, θl), where h is a new latent variable that helps
constrain the shape of lesions, as well as a joint likelihood
p(D|l, z, θd, θles) , where θles are new parameters that govern
their appearance. In the following, we summarize the segmen-
tation prior and the likelihood used in the augmented model, as
well as the way the resulting model is used to obtain automated
segmentations.
3.1. Segmentation prior
We use a joint segmentation prior of the form
p(l, z|h, θl) = p(z|h, θl)p(l|θl),
where p(l|θl) is the deformable atlas model defined in Sec-
tion 2.1, and
p(z|h, θl) =
I∏
i=1
p(zi|h, θl)
is a factorized model where the probability that a voxel is part
of a lesion is given by:
p(zi = 1||h, θl) = fi(h) ρi(θl).
1http://freesurfer.net/
Fig. 2: Graphical model of the proposed method. In black the existing contrast-
adaptive whole-brain segmentation method SAMSEG (without lesion model-
ing), in blue the proposed additional components to model also white matter
lesions. Shading indicates observed variables. The plate indicates I repetitions
of the included variables.
Here 0 ≤ fi(h) ≤ 1 aims to enforce shape constraints on lesions,
whereas 0 ≤ ρi(θl) ≤ 1 takes into account a voxel’s spatial
location within its neuroanatomical context. Below we provide
more details on both these components of the model.
3.1.1. Modeling lesion shapes
In order to model lesion shapes, we use a variational auto-
encoder (Kingma and Welling, 2013; Rezende et al., 2014) ac-
cording to which lesion segmentation maps z are generated in
a two-step process: An unobserved, low-dimensional code h
is first sampled from a spherical Gaussian distribution p(h) =
N(h|0, I), and subsequently “decoded” into z by sampling from
a factorized Bernoulli model:
pω(z|h) =
I∏
i=1
fi(h)zi (1 − fi(h))(1−zi) .
Here fi(h) are the outputs of a “decoder” convolutional neural
network (CNN) with filter weights ω, which parameterize the
model.
Given a training data set in the form of N binary segmen-
tation maps D = {z(n)}Nn=1, suitable network parameters ω can
in principle be estimated by maximizing the log-probability as-
signed to the data by the model:
log pω(D) =
∑
z∈D
log pω(z), where pω(z) =
∫
h
pω(zn|h)p(h) dh.
However, because the integral over the latent codes makes
this is intractable, we use amortized variational inference in
the form of stochastic gradient variational Bayes (Kingma and
Welling, 2013; Rezende et al., 2014). In particular, we intro-
duce an approximate posterior
qυ(h|z) = N
(
h |µυ(z), diag(σ2υ(z))
)
,
where the functions µυ(z) and συ(z) are implemented as an “en-
coder” CNN parameterized by υ. The variational parameters υ
are then learned jointly with the model parameters ω by max-
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imizing a variational lower bound
∑
z∈DLω,υ(z) ≤ log pω(D)
using stochastic gradient descent, where
Lω,υ(z) = −DKL(qυ(h|z)||p(h)) + Eqυ(h|z)
[
log pω(z|h)] . (3)
The first term is the Kullback-Leibler divergence between the
approximate posterior and the prior, which can be evaluated an-
alytically. The expectation in the last term is approximated us-
ing Monte Carlo sampling, using a change of variables (known
as the “reparameterization trick”) to reduce the variance in the
computation of the gradient with respect to υ (Kingma and
Welling, 2013; Rezende et al., 2014).
Our training data setD was derived from manual lesion seg-
mentations in 212 MS subjects, obtained from the University
Hospital of Basel, Switzerland. The segmentations were all
affinely registered and resampled to a 1mm isotropic grid of size
197 × 233 × 189. In order to reduce the risk of overfitting to
the training data, we augmented each segmentation in the train-
ing data set by applying a rotation of 10 degrees around each
axis, obtaining a total of 1484 segmentations. The architecture
for our encoder and decoder networks is detailed in Fig. 3. We
trained the model for 1000 epochs with mini-batch size of 10
using Adam optimizer (Kingma and Ba, 2014) with a learning
rate of 1e-4. We approximated the expectation in the variational
lower bound of Eq (3) by using a single Monte Carlo sample in
each step.
3.1.2. Modeling the spatial location of lesions
In order to encode the spatially varying frequency of occur-
rence of lesions across the brain, we model the probability of
finding a lesion in voxel i, based on its location alone, as
ρi(θl) =
J∑
j=1
β jψ
i
j(θl),
where lesion probabilities 0 ≤ β j ≤ 1 defined in the vertices
of the SAMSEG atlas mesh are interpolated at the voxel loca-
tion. This effectively defines a lesion probability map that de-
forms in conjunction with the SAMSEG atlas to match the neu-
roanatomy in each image being segmented, allowing the model
to impose contextual constraints on where lesions are expected
to be found.
We estimated the parameters β j by running SAMSEG on
MRI scans (T1-weighted (T1w) and FLAIR) of 54 MS sub-
jects in whom lesions had been manually annotated (data from
the University Hospital of Basel, Switzerland), and recording
the estimated atlas deformations. The parameters β j were then
computed from the manual lesion segmentations by applying
the same technique we used to estimate the αkj parameters in
the SAMSEG atlas training phase (cf. Sec. 2.1).
3.2. Likelihood function
For the likelihood, which links joint segmentations {l, z} to
intensities D, we use the same model as SAMSEG in vox-
els that do not contain lesion (zi = 0), but draw intensities
in lesions (zi = 1) from a separate Gaussian with parameters
θles = {µles,Σles}:
p(D|l, z, θd, θles) =
I∏
i=1
p(di|li, zi, θd, θles),
where
p(di|li = k, zi, θd, θles) =
N(di|µles + Cφi,Σles) if zi = 1,N(di|µk + Cφi,Σk) otherwise.
In order to constrain the values that the lesion intensity param-
eters θles can take, we make them conditional on the remaining
intensity parameters using a normal-inverse-Wishart distribu-
tion:
p(θles|θd) = N(µles|µWM , ν−1Σles)IW(Σles|κνΣWM , ν − N − 2).
(4)
Here the subscript “WM” denotes the white matter Gaussian
and κ > 1 and ν ≥ 0 are hyperparameters in the model.
This choice of model is motivated by the fact that the normal-
inverse-Wishart distribution is a conjugate prior for the param-
eters of a Gaussian distribution: Eq. (4) can be interpreted
has providing ν “pseudo-voxels” with empirical mean µWM and
variance κΣWM in scenarios where the lesion intensity parame-
ters µles and Σles need to be estimated from data. In the absence
of any such pseudo-voxels (ν = 0), Eq. (4) reduces to a flat
prior on θles and lesions are modeled as a completely indepen-
dent class. Although such models have been used in the liter-
ature (Guttmann et al., 1999; Kikinis et al., 1999; Shiee et al.,
2010; Sudre et al., 2015) their robustness may suffer when ap-
plied to subjects with no or very few lesions, such as controls
or patients with early disease, since there is essentially no data
to estimate the lesion intensity parameters from. In the other
extreme case, the number of pseudo-voxels can be set to such
a high value (ν → ∞) that the intensity parameters of the le-
sions are fully determined by those of WM. This effectively
replaces the Gaussian intensity model for WM in SAMSEG by
a distribution with longer tails, in the form of a mixture of two
Gaussians with identical means (µles ≡ µWM) but variances that
differ by a constant factor (Σles ≡ κΣWM vs. ΣWM). In this sce-
nario, MS lesions are detected as model outliers in a method us-
ing robust model parameter estimation, another technique that
has also frequently been used in the literature (Van Leemput
et al., 2001; Aı¨t-Ali et al., 2005; Bricq et al., 2008; Rousseau
et al., 2008; Prastawa and Gerig, 2008; Liu et al., 2009; Garcı´a-
Lorenzo et al., 2011).
Based on pilot experiments on a variety of datasets (distinct
from the ones used in the results section), we found that good
results are obtained by using an intermediate value of ν = 500
pseudo-voxels for 1mm3 isotropic scans, together with a scaling
factor κ = 50. In order to adapt to different image resolutions,
ν is scaled inversely proportionally with the voxel size in our
implementation. We will visually demonstrate the role of these
hyperparameters in constraining the lesion intensity parameters
in Sec. 3.4.
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(a) Decoder network architecture.
(b) Encoder network architecture.
Fig. 3: Lesion shape model architecture consisting of two symmetrical convolutional neural networks: (a) decoder network and (b) encoder network. The decoder
network generates lesion segmentations from a low-dimensional code. Its architecture has ReLU activation functions ( f (x) = max(0, x)) and batch normalization
(Ioffe and Szegedy, 2015) between each deconvolution layer, with the last layer having a sigmoid activation function, ensuring 0 ≤ fi(h) ≤ 1. The encoder network
encodes lesion segmentations into a latent code. The main differences compared to the decoder network are the use of convolutional layers instead of deconvolutional
layers and, to encode the mean and variance parameters, the last layer has been splitted in two, with no activation function for the mean and a softplus activation
function ( f (x) = ln(1 + ex)) for the variance.
3.3. Segmentation
As in the original SAMSEG method, segmentation proceeds
by first obtaining point estimates θˆ that fit the model to the data,
and then inferring the corresponding segmentation posterior:
p(l, z|D, θˆ),
which is now jointly over l and z simultaneously. Unlike in
SAMSEG, however, both steps are made intractable by the
presence of the new variables θles and h in the model. In order
to side-step this difficulty, we obtain θˆ through a joint optimiza-
tion over both θ and θles:
{θˆd, θˆles} = arg max{θd,θles} p(θd, θles|D)
in a simplified model in which the constraints on lesion shape
have been removed, by clamping all decoder network out-
puts fi(h) to value 1. This simplification is defensible since
the aim here is merely to find appropriate model parameters,
rather than highly accurate lesion segmentations. By doing so,
the latent code h is effectively removed from the model and
the optimization simplifies into the one used in the original
SAMSEG method, with only minor modifications due to the
prior p(θles|θd). Details are provided in Appendix B.
Once parameter estimates θˆ are available, we compute seg-
mentations using the factorization
p(l, z|D, θˆ) = p(z|D, θˆ)p(l|, z,D, θˆ),
first estimating z from p(z|D, θˆ), and then plugging this into
p(l|, z,D, θˆ) to estimate l:
1. Evaluating p(z|D, θˆ) involves marginalizing over both h
and θles, which we approximate by drawing S Monte Carlo
samples {h(s), θ(s)les}Ss=1 from p(h, θles|D, θˆ):
p(z|D, θˆ) =
∫
h,θles
p(z|D, θˆ,h, θles)p(h, θles|D, θˆ) dh, θles
' 1
S
S∑
s=1
p(z|D, θˆ,h(s), θ(s)les).
This allows us to estimate the probability of lesion occur-
rence in each voxel, which we then compare with a user-
specified threshold value γ
p(zi = 1|di, θˆ) ≷ γ
to obtain the final lesion segmentation zˆi. Details on how
we approximate p(zi = 1|di, θˆ) using Monte Carlo sam-
pling are provided in Appendix C.
2. Voxels that are not assigned to lesion (zˆi = 0) in the previ-
ous step are finally assigned to the neuroanatomical struc-
ture with the highest probability p(li = k|zi = 0,di, θˆ),
which simply involves computing lˆi = arg maxk wˆi,k with
wˆi,k defined in Eq. (2).
In agreement with other work (Van Leemput et al., 2001; Aı¨t-
Ali et al., 2005; Prastawa and Gerig, 2008; Shiee et al., 2010;
Garcı´a-Lorenzo et al., 2011; Jain et al., 2015), we have found
that using known prior information regarding the expected in-
tensity profile of MS lesions in various MRI contrasts can help
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reduce the number of false positive detections. Therefore, we
prevent some voxels from being assigned to lesion (i.e., forcing
zˆi = 0) based on their intensities in relation to the estimated
intensity parameters {µˆk, Σˆk}Kk=1: In our current implementation
only voxels with an intensity higher than the mean of the gray
matter Gaussian in FLAIR and/or T2 (if these modalities are
present) are considered candidate lesions.
Since estimating p(zi = 1|di, θˆ) involves repeatedly invoking
the decoder and encoder networks of the lesion shape model, as
detailed in Appendix C, we implemented the proposed method
as an add-on to SAMSEG in Python using the Tensorflow li-
brary (Abadi et al., 2015). Estimating θˆ has the same com-
putational complexity as running SAMSEG (i.e., taking ap-
proximately 10 minutes on a state-of-the-art machine), while
the Monte Carlo sampling takes an additional 5 minutes on a
GeForce GTX 1060 graphics card, bringing the total computa-
tion time to around 15 minutes per subject.
3.4. Illustration of the method
In order to illustrate the effect of the various components of
the method, here we analyze its behaviour when segmenting
T1w-FLAIR scans of two MS subjects – one with a low and one
with a high lesion load. Fig. 4 shows, in addition to the input
data and the final lesion probability estimate p(zi = 1|di, θˆ), also
an intermediate lesion probability obtained with the simplified
model used to estimate θˆ, i.e., before the FLAIR-based intensity
constraints and the lesion shape constraints are applied. From
these images we can see that the lesion shape model and the
intensity constraints help remove false positive detections and
enforce more realistic shapes of lesions, especially for the case
with low lesion load.
Fig. 5 analyzes the effect of the prior p(θles|θd) on the lesion
intensity parameters θles for the two subjects shown in Fig. 4.
When the lesion load is high, the prior does not have a strong
influence, leaving the lesion Gaussian “free” to fit the data.
However, when the lesion load is low, the lesion Gaussian is
constrained to retain a wide variance and a mean close to the
mean of WM, effectively turning the model into an outlier de-
tection method for WM lesions. This behavior is important in
cases when few lesions are present in the images, ensuring the
method works robustly even when only limited data is available
to estimate the lesion Gaussian parameters.
In order to demonstrate that the model also works robustly
in control subjects (with no lesions at all), and can therefore be
safely applied in studies comparing MS subjects with controls,
we further segmented T1w-FLAIR scans of 50 MS patients and
23 healthy control subjects (data taken from the Achieva dataset
described in Sec 4.1), and computed the total volume of the
lesions in each subject. The results are shown in Fig. 6; the
volumes were 8.95 ± 9.18 ml for MS subjects vs. 0.98 ± 0.77
ml for controls. Although the average lesion volume for con-
trols was not exactly zero, a visual inspection revealed that this
was due to some controls having WM hyperintensities that were
segmented by the method as MS lesions, which we find accept-
able.
4. Experiments
In this section, we describe three datasets that we will use
for the experiments in this paper. We also outline two state-of-
the-art methods for MS lesion segmentation that the proposed
method is benchmarked against, as well as the metrics and mea-
sures used in our experiments.
4.1. Datasets
In order to test the the proposed method and demon-
strate its contrast-adaptiveness, we conducted experiments on
three datasets acquired with different scanner platforms, field
strengths, acquisition protocols and image resolution:
- MSSeg: This dataset is the publicly available training set
of the MS lesion segmentation challenge that was held
in conjunction with the MICCAI 2016 conference (Com-
mowick et al., 2018). It consists of 15 MS cases from three
different scanners, all acquired using a harmonized imag-
ing protocol (Cotton et al., 2015). For each patient a 3D
T1w sequence naı¨ve and contrast-enhanced (T1c), an axial
dual PD-T2-weighted (T2w) sequence and a 3D fluid at-
tenuation inversion recovery (FLAIR) sequence were ac-
quired. Each subject’s lesions were delineated by seven
different raters on the FLAIR scan and, if necessary, cor-
rected using the T2w scan. These delineated images were
then fused to create a consensus lesion segmentation for
each subject. Both raw images and pre-processed images
(pre-processing steps: denoising, rigid registration, brain
extraction and bias field correction – see Commowick et al.
(2018) for details) were made available by the challenge
organizers. In our experiments we used the pre-processed
data, which required only minor modifications in our soft-
ware to remove non-brain tissues from the model. We note
that the original challenge also included a separate set of
38 test subjects, but at the time of writing this data is no
longer available.
- Trio: This dataset consists of 40 MS cases acquired on a
Siemens Trio 3T scanner at the Danish Research Center
of Magnetic Resonance (DRCMR). For each patient, a 3D
T1w sequence, a T2w sequence and a FLAIR sequence
were acquired. Ground truth lesion segmentations were
automatically delineated on the FLAIR images using Jim
software2, and then checked and, if necessary, corrected by
and expert rater at DRCMR using the T2w and MPRAGE
images.
- Achieva: This dataset consists of 50 MS cases and 25
healthy controls acquired on a Philips Achieva 3T scan-
ner at DRCMR. After a visual inspection of the images,
we decided to remove 2 healthy controls from the dataset
as they present marked gray matter atrophy and white mat-
ter hyperintensities. For each patient, a 3D T1w sequence,
a T2w sequence and a FLAIR sequence were acquired.
Ground truth lesion segmentations were delineated using
the same protocol as the one used for the Trio dataset.
2http://www.xinapse.com/
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Fig. 4: Illustration of how intensity constraints and the lesion shape model help reduce false positive lesion detections in the method. Top row: a subject with
a low lesion load; Bottom row: a subject with a high lesion load. From left to right: T1w and FLAIR input; intermediate lesion probability obtained with the
simplified model used to estimate θˆ; mask of candidate voxels based on intensity alone (intensity higher than the mean gray matter intensity in FLAIR); and final
lesion probability estimate p(zi = 1|di, θˆ) produced by the method.
Fig. 5: Illustration of the effect of the prior p(θles |θd) on the lesion intensity parameters, both in the case of a lesion load that is low (left, corresponding to the subject
in the top row of Fig. 4) and high (right, corresponding to the subject in the bottom row of Fig. 4). The illustration is from the Monte Carlo sampling phase of the
method: In each case, the value of the parameters of the lesion Gaussian is taken as the avarage over the Monte Carlo samples {θ(s)les}Ss=1, and the points represent the
resulting lesion posterior estimate p(zi = 1|di, θˆ) in each voxel.
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Fig. 6: Difference between healthy controls (HC) and MS subjects in lesion
volume, as detected by the proposed method on the Achieva dataset (23 HC
subjects, 50 MS subjects, T1w-FLAIR input). Lines indicate means across
subjects.
Dataset Scanner Modality Voxel resolution [mm] Subjects
MSSeg
Philips Ingenia 3T
3D FLAIR 0.74 × 0.74 × 0.7
5
3D T1w 0.74 × 0.74 × 0.85
3D T1c 0.74 × 0.74 × 0.85
2D T2w 0.45 × 0.45 × 3
2D PD 0.45 × 0.45 × 3
Siemens Aera 1.5T
3D FLAIR 1.03 × 1.03 × 1.25
5
3D T1w 1.08 × 1.08 × 0.9
3D T1c 1.08 × 1.08 × 0.9
2D T2w 0.72 × 0.72 × 4 (Gap: 1.2)
2D PD 0.72 × 0.72 × 4 (Gap: 1.2)
Siemens Verio 3T
3D FLAIR 0.5 × 0.5 × 1.1
5
3D T1w 1 × 1 × 1
3D T1c 1 × 1 × 1
2D T2w 0.69 × 0.69 × 3
2D PD 0.69 × 0.69 × 3
Trio Siemens Trio 3T
2D FLAIR 0.7 × 0.7 × 4
403D T1w 1 × 1 × 1
2D T2w 0.7 × 0.7 × 4
Achieva Philips Achieva 3T
3D FLAIR 1 × 1 × 1
733D T1w 0.85 × 0.85 × 0.85
3D T2w 0.85 × 0.85 × 0.85
Table 1: Summary of the datasets used in our experiments.
A summary of the datasets, with scanner type, image modal-
ities and voxel resolution details, can be found in Table 1. For
each subject all the contrasts were co-registered and resampled
to the FLAIR scan for MSSeg, and to the T1w scan for Trio
and Achieva. This is the only preprocessing step required by
the proposed method.
4.2. Benchmark methods for lesion segmentation
In order to evaluate the lesion segmentation component of
the proposed method, we benchmarked it against two publicly
available and widely used algorithms for MS lesion segmenta-
tion:
- LST-lga3 (Schmidt et al., 2012): This lesion growth algo-
rithm starts by segmenting a T1w image into three main
tissue classes (CSF, GM and WM) using SPM124, and
3https://www.applied-statistics.de/lst.html
4https://www.fil.ion.ucl.ac.uk/spm/software/spm12/
combines the resulting segmentation with co-registered
FLAIR intensities to calculate a lesion belief map. A pre-
chosen initial threshold κ is then used to create an initial bi-
nary lesion map, which is subsequently grown along vox-
els that appear hyperintense in the FLAIR image. We set
κ to its recommended default value of 0.3, which was also
used in previous studies (Mu¨hlau et al., 2013; Rissanen
et al., 2014).
- NicMsLesions5 (Valverde et al., 2017, 2019): This deep
learning method is based on a cascade of two 3D convolu-
tional neural networks, where the first one reveals possible
candidate lesion voxels, and the second one reduces the
number of false positive outcomes. Both networks were
trained on T1w and FLAIR scans coming from a publicly
available training dataset of the MS lesion segmentation
challenge held in conjunction with the MICCAI 2008 con-
ference (Styner et al., 2007) (20 cases) and the MSSeg
dataset (15 cases). This method was one of the top per-
formers on the test dataset of the MICCAI 2016 challenge
(Commowick et al., 2018), and one of the few methods for
which an implementation is publicly available.
We note that both these benchmark methods are specifically
targeting T1w-FLAIR input, whereas the proposed method is
not tuned to any particular combination of input modalities.
4.3. Metrics and measures
In order to evaluate the influence of varying the input modal-
ities on the segmentation performance of the proposed method,
and to assess segmentation accuracy with respect to that of other
methods and human raters, we used a combination of segmenta-
tion volume estimates, Pearson correlation coefficients between
such estimates and reference values, and Dice scores. Volumes
were computed by counting the number of voxels assigned to a
specific structure and converting into mm3, whereas Dice coef-
ficients were computed as
DiceX,Y =
2 · |X ∩ Y |
|X| + |Y | ,
where X and Y denote segmentation masks, and | · | counts the
number of voxels in a mask.
The proposed method and both benchmark algorithms pro-
duce a probabilistic lesion map that needs to be thresholded to
obtain a final lesion segmentation. This requires an appropri-
ate threshold value to be set for this purpose (variable γ in the
proposed method). In order to ensure an objective comparison
between the methods, we used a leave-one-out cross-validation
strategy in which the threshold for each test image was set to
the value that maximizes the average Dice overlap with manual
segmentations in all the other images of the same dataset.
5. Results
In this section, we first evaluate how the proposed model
adapts to different input modalities and acquisition platforms.
5https://github.com/sergivalverde/nicMsLesions
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We then compare the lesion segmentation performance of our
model against that of the two benchmark methods, and relate it
to human inter-rater variability. Finally, we perform an indirect
validation of the whole-brain segmentation component of the
method.
Throughout the section we use boxplots to show some of the
results. In these plots, the median is indicated by a horizontal
line, plotted inside boxes that extend from the first to the third
quartile values of the data. The range of the data is indicated by
whiskers extending from the boxes, with outliers represented
by circles.
5.1. Scanner and contrast adaptive segmentations
In order to demonstrate the ability of our method to adapt
to different types and combinations of MRI sequences acquired
with different scanners, we show the method’s segmentation re-
sults along with the manual segmentations for a representative
subset of combinations for one subject in the MSSeg (consensus
as manual segmentation), the Trio and the Achieva datasets in
Fig. 7. It is not feasible to show all possible combinations. For
instance, mixing the 5 contrasts in the MSSeg dataset alone al-
ready yields 31 possible multi-contrast combinations. Nonethe-
less, it is clear that the model is indeed able to adapt to the spe-
cific contrast properties of its input scans. A visual inspection
of its whole-brain segmentation component seems to indicate
that the method benefits from having access to the T1w con-
trast for best performance. This is especially clear when only
the FLAIR contrast is provided, as this visually degrades the
segmentation of the white-gray boundaries in the cortical re-
gions due to the low contrast between white and gray matter in
FLAIR.
When comparing the lesion probability maps produced by
the method visually with the corresponding manual lesion seg-
mentations, it seems that the method benefits from having ac-
cess to the FLAIR contrast for best lesion segmentation per-
formance. This is confirmed by a quantitative analysis shown
in Fig. 8, which plots the Dice overlap scores for each of the
seven input combinations that all our three datasets have in
common, namely T1w, T2w, FLAIR, T1w-T2w, T1w-FLAIR,
T2w-FLAIR, and T1w-T2w-FLAIR. Although the inclusion of
additional contrasts does not hurt lesion segmentation perfor-
mance, across all three datasets the best results are obtained
whenever the FLAIR contrast is included as input to the model.
This finding is perhaps not surprising, given that the manual
delineations were all primarily based on the FLAIR image.
Considering both the whole-brain and lesion segmentation
performance together, we conclude that the combination T1w-
FLAIR is well-suited for obtaining good results with the pro-
posed method, although it will also accept other and/or addi-
tional contrasts beyond T1w and FLAIR.
5.2. Lesion segmentation
In order to compare the lesion segmentation performance of
our model against that of the two benchmark methods, and re-
late it to human inter-rater variability, we here present a number
of results based on the T1w-FLAIR input combination (which
is the combination required by the benchmark methods).
Comparison with state-of-the-art lesion segmentation methods
Fig 9 shows automatic segmentations of two randomly se-
lected subjects from each dataset, both for our method and
for the two benchmark methods LST-lga and NicMSLesions,
along with the corresponding manual segmentations, where we
used the consensus manual segmentations for MSSeg. Visu-
ally, all three methods perform similarly on the Achieva MS
data, but some of the results for NicMSLesions appear to be in-
ferior to those obtained with the other two methods on MSSeg
and Trio data. This qualitative observation is confirmed by the
quantitative analysis shown in Fig. 10, where the three meth-
ods’ Dice overlap scores are compared on each dataset: simi-
lar performances are obtained for all methods on Achieva data,
but NicMSLesions trails the other two methods on MSSeg and
Trio data. Especially for MSSeg data this is a surprising result,
since NicMSLesions was trained on this specific dataset, i.e.,
the subjects used for testing were part of the training data of
this method, potentially biasing the results in favor of NicM-
SLesions. Based on Dice scores, the proposed method outper-
forms LST-lga on MSSeg data, although there are no statisti-
cally significant differences between the two methods on the
other datasets.
Fig. 11 summarizes a final quantitative analysis. For each
of the three methods, the automatically computed lesion vol-
umes are plotted against the manually determined ones. In
these plots, which pool results across all three datasets, Pear-
son correlation coefficients and linear regression lines are also
indicated. All three methods replicate manual volumetry rea-
sonably well, although NicMSLesions seems to suffer from a
number of outliers decreasing the correlation.
Taken together, we conclude that the lesion segmentation
performance of the proposed method is on par with the current
state of the art method used in the field.
Inter-rater variability
We evaluated the proposed method’s lesion segmentation
performance in the context of human inter-rater variability, tak-
ing advantage of the availability of lesion segmentations by
seven different raters in the MSSeg dataset. Table 2 shows the
Pearson correlation coefficient of lesion volume estimates be-
tween each pair of raters, as well as between each rater and
the proposed method on this dataset. The average correlation
coefficient between one rater and the six others is in the range
[0.91, 0.97] (bottom row of the table), whereas between our
method and all human raters it is 0.95 on average, which falls
well within the range of human inter-rater variability. When the
degree of spatial overlap is taken into account, however, the hu-
man raters are in stronger agreement between themselves than
with the proposed method: Table 3 shows the lesion segmen-
tation performance in terms of average Dice overlap between
each pair of the seven raters, and between each rater and the
proposed method. On average, our method achieves a Dice
overlap score of 0.57, which is slightly below the mean human
raters’ range of [0.59, 0.69].
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Fig. 7: Contrast-adaptiveness of the proposed method to different combinations of input modalities. Segmentations are shown for one subject of the MSSeg (top
row), the Trio (middle row) and the Achieva MS (bottom row) dataset. For each subject the top row shows slices of the data and the manual lesion annotation;
the middle row shows the lesion probability map computed by the proposed method for specific input combinations; and the bottom row shows the corresponding
complete segmentations produced by the method.
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(a) MSSeg Dice scores. (b) Trio Dice scores. (c) Achieva MS Dice scores.
Fig. 8: Lesion segmentation performance of the proposed method in terms of Dice overlap with manual raters on three different datasets when different input
contrasts are used (T1w, T2w, FLAIR, T1w-T2w, T1w-FLAIR, T2w-FLAIR, T1w-T2w-FLAIR). From left to right: Dice scores on MSSeg, Trio and Achieva MS
data.
R1 R2 R3 R4 R5 R6 R7 Ours
R1 - 0.96 0.93 0.96 0.97 0.93 0.82 0.89
R2 0.96 - 0.96 0.97 0.98 0.96 0.89 0.95
R3 0.93 0.96 - 0.98 0.96 0.95 0.93 0.96
R4 0.96 0.97 0.98 - 0.99 0.97 0.93 0.97
R5 0.97 0.98 0.96 0.99 - 0.97 0.91 0.96
R6 0.93 0.96 0.95 0.97 0.97 - 0.95 0.95
R7 0.82 0.89 0.93 0.93 0.91 0.95 - 0.96
Avg 0.93 0.95 0.95 0.97 0.96 0.96 0.91 0.95
Table 2: Pearson correlation coefficients of lesion volume estimates between
each pair of the seven raters of the MSSeg dataset, and between each rater and
the proposed method (T1w-FLAIR input).
R1 R2 R3 R4 R5 R6 R7 Ours
R1 - 0.68 0.59 0.70 0.75 0.59 0.59 0.54
R2 0.68 - 0.59 0.71 0.72 0.60 0.57 0.56
R3 0.59 0.59 - 0.57 0.59 0.60 0.63 0.60
R4 0.70 0.71 0.57 - 0.90 0.57 0.54 0.53
R5 0.75 0.72 0.59 0.90 - 0.59 0.57 0.55
R6 0.59 0.60 0.60 0.57 0.59 - 0.61 0.57
R7 0.59 0.57 0.63 0.54 0.57 0.61 - 0.60
Avg 0.65 0.64 0.60 0.66 0.69 0.60 0.59 0.57
Table 3: Comparison of lesion segmentation performance in terms of average
Dice score between each pair of the seven raters of the MSSeg dataset, and
between each rater and the proposed method (T1w-FLAIR input).
5.3. Whole-brain segmentation
Since no ground truth segmentations are available for a di-
rect evaluation of the whole-brain segmentation component of
our method, we performed an indirect validation, evaluating
its potential for replacing lesion filling approaches that rely on
manually annotated lesions, as well as its ability to replicate
known atrophy patterns in MS. The results concentrate on the
following 25 main neuroanatomical regions, segmented from
T1w-FLAIR scans: left and right cerebral white matter, cere-
bellum white matter, cerebral cortex, cerebellum cortex, lateral
ventricle, hippocampus, thalamus, putamen, pallidum, caudate,
amygdala, nucleus accumbens and brain stem. To avoid clutter-
ing, the quantitative results for left and right structures are aver-
aged. We specify that lesion segmentations are not merged into
any of these brain structures (i.e., leaving “holes” in white mat-
ter), so that the results reflect performance only for the normal-
appearing parts of structures.
Comparison with lesion filling
It is well-known that white matter lesions can severely
interfere with the quantification of normal-appearing struc-
tures when standard brain MRI segmentation techniques are
used (Chard et al., 2010; Battaglini et al., 2012; Gelineau-Morel
et al., 2012; Ceccarelli et al., 2012; Nakamura and Fisher, 2009;
Vrenken et al., 2013). A common strategy is therefore to use
a lesion-filling (Sdika and Pelletier, 2009; Chard et al., 2010)
procedure, in which lesions are first manually segmented, their
original voxel intensities are replaced with normal-appearing
white matter intensities, and standard tools are then used to
segment the resulting, preprocessed images. Using such a pro-
cedure with SAMSEG would yield whole-brain segmentations
that can serve as “silver standard” benchmarks against which
the results of the proposed method (which works directly on
the original scans) can be compared. In practice, however, we
have noticed that replacing lesion intensities, which is typically
done in T1w only, did not work well in FLAIR in our exper-
iments. Therefore, rather than explicitly replacing intensities,
we obtained silver standard segmentations by simply masking
out lesions during the SAMSEG processing, effectively ignor-
ing lesion voxels during the model fitting.
We wished to interpret segmentation vs. silver standard dis-
crepancies within the context of the human inter-rater variabil-
ity associated with manually segmenting lesions. Therefore,
we performed experiments on the MSSeg dataset, repeatedly
re-computing the silver standard using each of the seven raters’
manual lesion annotations in turn. The results are shown in
Tables 4 and 5 for Pearson correlation coefficients between
estimated volumes and Dice segmentation overlap scores, re-
spectively. Each line in these tables corresponds to one struc-
ture, showing the average consistency between the silver stan-
dard of each rater compared to that of the six other raters, as
well as the average consistency between the proposed method’s
segmentation and the silver standards of all raters. The re-
sults indicate that, in terms of Pearson correlation coefficient,
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Fig. 9: Visual comparison of lesion probability maps on three different datasets for the proposed method and two state-of-the-art lesion segmentation methods (LST-
lga and NicMsLesions) on T1w-FLAIR input. (Top) Two subjects from the MSSeg dataset; (Middle) Two subjects from the Trio dataset; (Bottom) Two subjects
from the Achieva dataset. For each subject the top row shows slices of the data and the manual annotation while the bottom row shows the lesion probability maps
for our model, LST-lga and NicMsLesions.
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(a) MSSeg Dice Scores. (b) Trio Dice Scores. (c) Achieva MS Dice Scores.
Fig. 10: Lesion segmentation performance in terms of Dice overlap with manual raters for the proposed method and two benchmark methods (LST-lga and
NicMsLesions) on T1w-FLAIR input. Statistically significant differences between two methods, computed with a two-tailed paired t-test, are indicated by asterisks
(“***” for p-value < 0.001, “**” for p-value < 0.01 and “*” for p-value < 0.05). From left to right: results on the MSSeg, the Trio and the Achieva dataset.
(a) Volume correlation of the proposed model. (b) Volume correlation of LST-lga. (c) Volume correlation of NicMsLesions.
Fig. 11: Lesion segmentation performance in terms of volume correlation with manual raters across three different datasets for the proposed method and two
benchmark methods (LST-lga and NicMsLesions) on T1w-FLAIR input. From left to right: proposed model, LST-lga and NicMsLesions.
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the performance of our method falls within the range of inter-
rater variability, albeit narrowly (average value 0.988 vs. inter-
rater range [0.988, 0.992]). In terms of Dice scores, however,
the method slightly underperforms compared to the inter-rater
variability (average value 0.971 vs. inter-rater range [0.978,
0.980]).
Detecting atrophy patterns in MS
In a final analysis, we assessed whether previously reported
volume reductions in specific brain structures in MS can au-
tomatically be detected with the proposed method. Towards
this end, we segmented the 23 controls and the 50 MS sub-
jects of the Achieva dataset, and compared the volumes of var-
ious structures between the two groups. Volumes were normal-
ized for age, gender and total intracranial volume by regressing
them out with a general linear model. The intracranial volume
used for the normalization was computed by summing the vol-
umes of all the structures, as segmented by the method, within
the intracranial vault. The results are shown in Fig. 12. Al-
though not all volumes showed significant difference between
groups, well established differences were replicated. In particu-
lar, we demonstrated decreased volumes of cerebral white mat-
ter, cerebral cortex, thalamus and caudate (Chard et al., 2002;
Houtchens et al., 2007; Azevedo et al., 2018) as well as an in-
creased volume of the lateral ventricles (Zivadinov et al., 2016).
6. Discussion and conclusion
In this paper, we have proposed a method for the simul-
taneous segmentation of white matter lesions and normal-
appearing neuroanatomical structures from multi-contrast brain
MRI scans of MS patients. The method integrates a novel
model for white matter lesions into a previously validated gen-
erative model for whole-brain segmentation. By using separate
models for the shape of anatomical structures and their appear-
ance in MRI, the algorithm is able to adapt to data acquired
with different scanners and imaging protocols without need-
ing to be retrained. We validated the method using three dis-
parate datasets, showing state-of-the-art performance in white
matter lesion segmentation while simultaneously segmenting
dozens of other brain structures. We further demonstrated that
it can also be applied robustly to MRI scans of healthy controls,
and replicate previously documented atrophy patterns in deep
gray matter structures in MS. The proposed algorithm is pub-
licly available as part of the open-source neuroimaging package
FreeSurfer.
By performing both whole-brain and white matter lesion seg-
mentation at the same time, the method we propose aims to
supplant the two-stage “lesion filling” procedure that is com-
monly used in morphometric studies in MS, in which lesions
segmented in a first step are used to avoid biasing a subse-
quent analysis of normal-appearing structures with software
tools developed for healthy brain scans. In order to evaluate
whether our method is successful in this regard, we compared
its whole-brain segmentation performance against the results
obtained when lesions are segmented a priori by seven differ-
ent human raters instead of automatically by the method itself.
Our results show that the volumes of various neuroanatomi-
cal structures obtained when lesions are segmented automati-
cally fall within the range of inter-rater variability, indicating
that the proposed method may be used instead of lesion filling
with manual lesion segmentations in large volumetric studies
of brain atrophy in MS. When detailed spatial overlap is ana-
lyzed, however, we found that the automatic segmentation does
not fully reach the performance obtained with human lesion an-
notation as measured by Dice overlap. Similar results were
obtained when we analyzed the segmentation performance of
the lesions themselves: while automatically obtained lesions
fell within the range of human inter-rater variability in terms of
volumetry, in terms of spatial overlap agreement between hu-
man experts was still higher than what can be achieved with the
proposed method. We note, however, that the latter result is in
line with recent research analyzing the performance of the best
lesion segmentation methods currently available (Commowick
et al., 2018).
For biological validation, we also compared brain volumes
segmented by the method between patients with MS and
healthy controls. We demonstrated well established alterations
of brain volumes in MS. In other words, these group compar-
isons did not indicate that the integration of the white matter
lesion segmentation component into the model disturbs the seg-
mentation of anatomical structures.
Like many other methods for MS lesion segmentation, the
method proposed here produces a spatial map indicating in each
voxel its probability of belonging to a lesion, which can then
be thresholded to obtain a final lesion segmentation. Although
in our experience good results can be obtained by using the
same threshold value across datasets (e.g., γ = 0.5), chang-
ing this value allows one to adjust the trade-off between false
positive and false negative lesion detections. Since some MRI
sequences and scanners will depict lesions with a higher con-
trast than others, and because there is often considerable dis-
agreement between human experts regarding the exact extent
of lesions (Zijdenbos et al., 1998), in our implementation we
therefore expose this threshold value as an optional, tunable pa-
rameter to the end-user. Suitable threshold values can be found
by visually inspecting the lesion segmentations of a few cases
or, in large-scale studies, using cross-validation as we did in our
experiments.
By providing the ability to robustly and efficiently segment
multi-contrasts scans of MS patients across a wide range of
imaging equipment and protocols, the software tool presented
here may help facilitate large cohort studies aiming to eluci-
date the morphological and temporal dynamics underlying dis-
ease progression and accumulation of disability in MS. Fur-
thermore, in current clinical practice, high-resolution multi-
contrast images, which can be used to increase the accuracy
of lesion segmentation, represent a significantly increased bur-
den for the neuroradiologist to read, and are hence frequently
not acquired. The emergence of robust, multi-contrast segmen-
tation tools such as ours may help break the link between the
resolution and number of contrasts of the acquired data and the
human time needed to evaluate it, thus potentially increasing
the accuracy of the resulting measures.
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R1 R2 R3 R4 R5 R6 R7 Ours
Cerebral White Matter 0.992 0.992 0.991 0.993 0.993 0.993 0.987 0.989
Cerebellum White Matter 0.994 0.997 0.997 0.996 0.997 0.997 0.997 0.989
Cerebral Cortex 0.997 0.999 0.999 0.999 0.999 0.999 0.999 0.997
Cerebellum Cortex 0.999 0.999 0.997 0.999 0.997 0.999 0.999 0.999
Lateral Ventricles 0.996 0.995 0.996 0.997 0.998 0.994 0.996 0.992
Hippocampus 0.982 0.989 0.987 0.979 0.977 0.979 0.984 0.981
Thalamus 0.998 0.997 0.998 0.998 0.998 0.997 0.997 0.996
Putamen 0.999 0.999 0.999 0.999 0.999 0.999 0.999 0.996
Pallidum 0.988 0.993 0.993 0.994 0.993 0.994 0.990 0.989
Caudate 0.994 0.993 0.987 0.990 0.995 0.989 0.993 0.985
Amygdala 0.953 0.967 0.970 0.973 0.941 0.957 0.972 0.963
Accumbens 0.985 0.987 0.987 0.966 0.989 0.953 0.988 0.971
Brain Stem 0.991 0.994 0.990 0.992 0.992 0.988 0.992 0.989
Average 0.990 0.992 0.992 0.990 0.990 0.988 0.992 0.988
Table 4: Average Pearson correlation coefficients of brain structure volume
estimates between the silver standard of each rater compared to that of the six
other raters in the MSSeg dataset, as well as the average consistency between
the proposed method’s segmentation and the silver standards of all raters (T1w-
FLAIR input). Each line shows an average across raters – similar to the last
row of Table 2 – for a specific brain structure.
R1 R2 R3 R4 R5 R6 R7 Ours
Cerebral White Matter 0.982 0.982 0.982 0.983 0.983 0.982 0.981 0.978
Cerebellum White Matter 0.987 0.987 0.987 0.987 0.988 0.987 0.987 0.983
Cerebral Cortex 0.989 0.990 0.989 0.990 0.989 0.989 0.989 0.986
Cerebellum Cortex 0.996 0.996 0.995 0.996 0.996 0.995 0.995 0.994
Lateral Ventricles 0.972 0.970 0.972 0.974 0.976 0.971 0.971 0.954
Hippocampus 0.975 0.972 0.971 0.973 0.974 0.972 0.972 0.965
Thalamus 0.980 0.981 0.981 0.982 0.981 0.982 0.981 0.975
Putamen 0.987 0.987 0.988 0.988 0.988 0.988 0.987 0.980
Pallidum 0.985 0.985 0.986 0.986 0.986 0.986 0.985 0.978
Caudate 0.961 0.957 0.956 0.961 0.964 0.957 0.954 0.937
Amygdala 0.973 0.972 0.972 0.973 0.972 0.972 0.972 0.967
Accumbens 0.957 0.958 0.960 0.960 0.960 0.943 0.960 0.945
Brain Stem 0.987 0.986 0.984 0.986 0.986 0.986 0.986 0.983
Average 0.979 0.979 0.979 0.980 0.980 0.978 0.978 0.971
Table 5: Same as Table 4, but with Dice segmentation overlap scores. Each
line shows an average across raters – similar to the last row of Table 3 – for a
specific brain structure.
The ability of the proposed method to automatically tailor
its appearance models for specific datasets makes it very flex-
ible, allowing it to seamlessly take advantage of novel, po-
tentially more sensitive and specific MRI acquisitions as they
are developed. Although not extensively tested, the proposed
method should make it possible to, with minimal adjustments,
segment data acquired with advanced research sequences such
as MP2RAGE (Marques et al., 2010), DIR (Redpath and Smith,
1994), FLAIR2 (Wiggermann et al., 2016) or T2* (Anderson
et al., 2001), both at conventional and at ultra-high magnetic
field strengths. We are currently pursuing several extensions of
the proposed method, including the ability to go on and create
cortical surfaces and parcellations in FreeSurfer, as well as a
dedicated version for longitudinal data.
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Appendix A. Parameter optimization in SAMSEG
We here describe how we perform the optimization of p(θ|D)
with respect to θ in the original SAMSEG model. We follow a
coordinate ascent approach, in which a limited-memory BFGS
optimization of θl is interleaved with a generalized EM (GEM)
optimization of the remaining parameters θd. The GEM algo-
rithm was derived in (Van Leemput et al., 1999) based on (Wells
et al., 1996), and is repeated here for the sake of complete-
ness. It iteratively constructs a tight lower bound to the objec-
tive function by computing the soft label assigments wi,k based
on the current estimate of θd (Eq. (2)), and subsequently im-
proves the lower bound (and therefore the objective function)
using the following set of analytical update equations for these
parameters:
µk ← mk and Σk ← Vk, ∀k
c1
...
cN
←

AT S1,1A . . . AT S1,NA
...
. . .
...
AT SN,1A . . . AT SN,NA

−1 
AT
(∑N
n=1 S1,nr1,n
)
...
AT
(∑N
n=1 SN,nrN,n
)
 ,
where
mk =
∑I
i=1 wi,k(di − Cφi)
Nk
with Nk =
I∑
i=1
wi,k,
Vk =
∑I
i=1 wi,k(di − Cφi −mk)(di − Cφi −mk)T
Nk
,
A =

φ11 . . . φ
1
P
...
. . .
...
φI1 . . . φ
I
P
 , Sm,n = diag (sm,ni ) , rm,n =

rm,n1
...
rm,nI

and
sm,ni =
K∑
k=1
sm,ni,k , s
m,n
i,k = wi,k
(
Σ−1k
)
m,n
, rm,ni = d
n
i −
∑K
l=1 s
m,n
i,k
(
µk
)
n∑K
l=1 s
m,n
i,k
.
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Fig. 12: Differences between healthy controls (HC) and MS subjects in normalized volume estimates of various neuroanatomical structures, as detected by the
proposed method on the Achieva dataset (23 HC subjects, 50 MS subjects, T1w-FLAIR input). Statistically significant differences between the two groups,
computed with a Welch’s t-test, are indicated by asterisks (“**” for p-value < 0.01 and “*” for p-value < 0.05).
Appendix B. Parameter optimization
Here we describe how we perform the optimization of
p(θ, θles|D) with respect to θ and θles in the augmented model
of Sec. 3 with the decoder outputs fi(h) all clamped to value 1.
In that case, the model can be reformulated in the same form
as the original SAMSEG model, so that the same optimization
strategy can be used. In particular, lesions can be considered to
form an extra class (with index K+1) in a SAMSEG model with
K + 1 labels, provided that the mesh vertex label probabilities
α˜kj =
β j if k = K + 1 (lesion),αkj(β j − 1) otherwise.
are used instead of the original αkj’s in the atlas interpolation
model of Eq. (1).
The optimization described in Appendix A does require one
modification because of the prior p(θles|θd) binding the means
and variances of the WM and lesion classes together. The fol-
lowing altered update equations for these parameters guarantee
that the EM lower bound, and therefore the objective function,
is improved in each iteration of the GEM algorithm:
µWM ←
(
NWMI +
νNWM
ν + NWM
ΣWMΣ
−1
les
)−1
(
NWMmWM +
νNWM
ν + NWM
ΣWMΣ
−1
lesmles
)
,
ΣWM ← NWMVWM + ΣlesΣ
−1
WMΨles
NWM + Nles + N + 2
,
µles ←
Nlesmles + νµWM
Nles + ν
,
Σles ← Ψles + νκΣWMNles + ν ,
where Ψles =
Nlesν
Nles + ν
(mles − µWM)(mles − µWM)T + NlesVles.
Appendix C. Estimating lesion probabilities
We here describe how we we approximate p(zi = 1|di, θˆ)
using Monte Carlo sampling. We use a Markov chain Monte
Carlo (MCMC) approach to sample triplets {θ(s)les, z(s),h(s)} from
the distribution p(θles, z,h|D, θˆ): Starting from an initial lesion
segmentation z(0) obtained from the parameter estimation pro-
cedure described in Appendix B, we use a blocked Gibbs sam-
pler in which each variable is updated conditioned on the other
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ones:
Σ
(s+1)
les ∼ p(Σles|D, θˆ, z(s)) =
IW
(
Σles
∣∣∣Ψ(s)les + νκΣˆWM , N(s)les + ν − N − 2)
µ(s+1)les ∼ p(µles|D, θˆ, z(s),Σ(s+1)les ) =
N
µles ∣∣∣∣∣ N(s)lesm(s)les + νµˆWMN(s)les + ν ,
Σ
(s+1)
les
N(s)les + ν

h(s+1) ∼ p(h|z(s)) ' N
(
h
∣∣∣µυ(z(s)), diag(σ2υ(z(s))))
z(s+1) ∼ p(z|D, θˆ,h(s+1), θ(s+1)les ) =
I∏
i=1
p(zi|di, θˆ,h(s+1), θ(s+1)les ),
where we use the encoder variational approximation obtained
during the training of the lesion shape model (see Sec. 3.1.2) to
sample from h in the next-to-last step, and
p(zi = 1|di, θˆ,h, θles) = N(di|µles + Cφi,Σles) fi(h)ρi(θˆl)∑K
li=1
∑1
z′i =0
p(di|li, z′i , θˆl, θles)p(z′i |θˆl,h)p(li|θˆl)
in the last step. In these equations, the variables N(s)les, m
(s)
les,
V(s)les andΨ
(s)
les are as defined before, but using voxel assignments
wi,les = z
(s)
i . Once S samples are obtained, we approximate
p(zi = 1|di, θˆ) as
p(zi = 1|di, θˆ) ' 1S
S∑
s=1
p(zi = 1|di, θˆ,h(s), θ(s)les).
In our implementation, we use S = 50 samples, obtained
after discarding the first 50 sweeps of the sampler (so-called
“burn-in” phase). The algorithm repeatedly invokes the decoder
and encoder networks of the lesion shape model described in
Sec. 3.1.2. Since this shape model was trained in a specific
isotropic space, the algorithm requires transitioning between
this training space and subject space using an affine transforma-
tion. This is accomplished by resampling the input and output
of the encoder and decoder, respectively, using linear interpola-
tion.
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